Senseonics Holdings, Inc. (SENS)
USD 0.68
(13.3%)
USD 0.68
(13.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 64.76 Million USD | -64.07% |
| 2022 | 180.24 Million USD | -53.12% |
| 2021 | 384.46 Million USD | 113.59% |
| 2020 | 180 Million USD | 27.26% |
| 2019 | 141.44 Million USD | 59.45% |
| 2018 | 88.71 Million USD | 129.37% |
| 2017 | 38.67 Million USD | 42.47% |
| 2016 | 27.14 Million USD | 78.73% |
| 2015 | 15.18 Million USD | 25.72% |
| 2014 | 12.08 Million USD | 413808.87% |
| 2013 | 2919.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 102 Million USD | 1.17% |
| 2023 Q4 | 73.32 Million USD | 4.91% |
| 2023 Q3 | 69.89 Million USD | 7.92% |
| 2023 FY | 64.76 Million USD | -64.07% |
| 2023 Q2 | 64.76 Million USD | -36.5% |
| 2022 Q1 | 197.73 Million USD | 24.06% |
| 2022 Q2 | 180.24 Million USD | -8.84% |
| 2022 Q3 | 94.06 Million USD | -47.81% |
| 2022 Q4 | 100.82 Million USD | 7.18% |
| 2022 FY | 180.24 Million USD | -53.12% |
| 2021 Q3 | 277.56 Million USD | -27.8% |
| 2021 FY | 384.46 Million USD | 113.59% |
| 2021 Q1 | 486.27 Million USD | -11.23% |
| 2021 Q2 | 384.46 Million USD | -20.94% |
| 2021 Q4 | 159.38 Million USD | -42.58% |
| 2020 Q1 | 98.84 Million USD | 22.88% |
| 2020 Q3 | 381.84 Million USD | 112.14% |
| 2020 Q4 | 547.76 Million USD | 43.45% |
| 2020 FY | 180 Million USD | 27.26% |
| 2020 Q2 | 180 Million USD | 82.1% |
| 2019 Q3 | 84.23 Million USD | -40.45% |
| 2019 Q2 | 141.44 Million USD | -0.18% |
| 2019 Q1 | 141.69 Million USD | 70.26% |
| 2019 Q4 | 80.44 Million USD | -4.5% |
| 2019 FY | 141.44 Million USD | 59.45% |
| 2018 Q2 | 88.71 Million USD | -16.88% |
| 2018 Q4 | 83.22 Million USD | -2.61% |
| 2018 Q3 | 85.45 Million USD | -3.67% |
| 2018 FY | 88.71 Million USD | 129.37% |
| 2018 Q1 | 106.72 Million USD | 3.67% |
| 2017 Q1 | 37.88 Million USD | 7.86% |
| 2017 FY | 38.67 Million USD | 42.47% |
| 2017 Q4 | 102.95 Million USD | 13.14% |
| 2017 Q3 | 90.99 Million USD | 135.26% |
| 2017 Q2 | 38.67 Million USD | 2.08% |
| 2016 Q1 | 23.78 Million USD | -1.8% |
| 2016 FY | 27.14 Million USD | 78.73% |
| 2016 Q4 | 35.12 Million USD | 6.22% |
| 2016 Q3 | 33.06 Million USD | 21.81% |
| 2016 Q2 | 27.14 Million USD | 14.12% |
| 2015 Q1 | 49.14 Thousand USD | 5.67% |
| 2015 Q4 | 24.22 Million USD | 29.77% |
| 2015 Q3 | 18.66 Million USD | 23.47% |
| 2015 Q2 | 15.12 Million USD | 30667.98% |
| 2015 FY | 15.18 Million USD | 25.72% |
| 2014 Q1 | 18.99 Thousand USD | 0.0% |
| 2014 Q3 | 18.59 Thousand USD | -4.13% |
| 2014 Q4 | 46.5 Thousand USD | 150.15% |
| 2014 FY | 12.08 Million USD | 413808.87% |
| 2014 Q2 | 19.39 Thousand USD | 2.11% |
| 2013 FY | 2919.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | 3.44 Million USD | -1777.878% |
| Electromed, Inc. | 8.34 Million USD | -676.595% |
| Catheter Precision, Inc. | 9.54 Million USD | -578.625% |
| Xtant Medical Holdings, Inc. | 41.26 Million USD | -56.964% |